BioSpace News Archive

A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database , a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets made available to public health and policy researchers to extract insights to help combat the COVID-19 pandemic. The database is a

Mogrify Ltd (Mogrify ® ), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics (Sangamo) (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a collaboration and exclusive license agreement for Sangamo to develop allogeneic cell therapies from Mogrify’s proprietary induce

Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT ® , its non-invasive and flexible continuous glucose monitor (“CGM”), today announced it has secured a 24-month, $5 million non-convertible loan. The loan does not include warrants or other equity securities.

Aptose Biosciences Inc. will release its financial results for the quarter ended March 31, 2020, on Tuesday, May 5, 2020, after the close of the market. Conference Call & Webcast: Date: Tuesday, May 5, 2020 Time: 5:00 PM Eastern Time Dial In - Tol

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead product candidate, PBGM01, for the treatment of infantile GM1 gangliosidosis (GM1). GM1 is a rare and often life-threatening monogenic recessive lysosomal storage disease ca

Internationally renowned ophthalmologist, Gerd Auffarth, MD, ranked as one of the “100 most influential personalities in ophthalmology worldwide” in the 2020 Power List published by The Ophthalmologist magazine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. “These early pre-clinical results are in line with those for our oral

Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, announced that its CEO, Waqaas Al-Siddiq, was recently interviewed on Newsmax to discuss Remote Patient Monitoring, Telemedicine and how Biotricity and its Bioflux solution is currently being used to remotely monitor patients. “It is exciting and humbling to have the Company and our technology recognized as a leader. Remote Diagnost

Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2020 after the close of U.S. financial markets on Monday, May 4, 2020 . Do

Hope Biosciences announces FDA approval on their third clinical trial for COVID-19. This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics . The hospital has an entire floor dedicated to treating COVID-19 patients, with staff specifically trained to care for these patients.